Skip to main content
OpenTrials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

367 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

NSCLC trial results

Completed

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

NCT03562871

Conditions
NSCLC
Locations
  • Thoraxklinik Heidelberg gGmbH Heidelberg, Community of Heidelberg, Germany
  • PIUS Hospital Oldenburg Oldenburg, Germany
  • Stichting Het Nederlands Kanker Instituut Amsterdam, Community of Amsterdam, Netherlands
  • Servicio de Oncología-El médico del Virgen de la Victoria Málaga, Andalusia, Spain
View all 13 locations
View Trial Details
Completed

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

NCT03794544

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site Leesburg, Florida, United States
  • Research Site Baltimore, Maryland, United States
View all 18 locations
View Trial Details
Completed

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

NCT02573259

Conditions
Carcinoma, Carcinoma, Transitional Cell, Melanoma, +21 more
Locations
  • Clinical Research Unit Los Angeles, California, United States
  • Ronald Reagan Medical Center, Department of Radiological Sciences Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
View all 67 locations
View Trial Details

Related conditions